Oral Session 2-7B PTCL/NK lymphoma: Treatment (1)

[OS2-7B-6] A clinicopathological analysis of CD56-positive cutaneous T cell lymphoma

Tetsuro Ochi¹, Noriko Fukuhara¹, Sayaka Sano¹, Kentaro Nasu², Masahiro Kobayashi³, Satoshi Ichikawa¹, Yoko Okitsu⁴, Yasushi Onishi¹, Minami Fujiwara⁵, Taku Fujimura⁶, Ryo Ichinohasama⁷, Hideo Harigae¹ (1.Department of hematology and rheumatology, Tohoku University hospital, Sendai, Japan, 2.Department of Hematology, Osaki citizen Hospital, Osaki, Japan, 3.Department of hematology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 4.Department of Transfusion, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 5.Department of blood transfusion, Tohoku University hospital, Sendai, Japan, 6.Department of dermatology, Tohoku University hospital, Sendai, Japan, 7.Department of hematopathology,Tohoku University hospital, Sendai, Japan)